Resting Heart Rate and Long-Term Outcomes in Patients with Percutaneous Coronary Intervention: Results from a 10-Year Follow-Up of the CORFCHD-PCI Study

Table 5

Multivariable Cox regression analysis of MACEs.

Variables	B	SE	Wald	value	HR (95% CI)
Age	−0.001	0.004	0.153	0.696	0.999 (0.991–1.006)
SBP	−0.002	0.002	0.834	0.361	0.998 (0.993–1.003)
DBP	0.003	0.004	0.373	0.541	1.003 (0.994–1.011)
Diabetes	0.162	0.090	3.246	0.072	1.176 (0.986–1.402)
Hypertension	0.291	0.082	12.565	0.000	1.338 (1.139–1.572)
ML	0.249	0.089	7.860	0.005	1.283 (1.078–1.527)
CTO	0.311	0.089	12.232	0.000	1.364 (1.146–1.624)
Aspirin	−0.551	0.090	37.720	0.000	0.577 (0.484–0.687)
Statins	−0.008	0.095	0.007	0.934	0.992 (0.824–1.195)
β-Blockers	−0.086	0.092	0.869	0.351	0.918 (0.766–1.099)
LVEDD	−0.013	0.008	2.674	0.102	0.987 (0.972–1.003)
LVEF	−0.006	0.006	0.878	0.349	0.994 (0.982–1.006)
Heart rate (<66 beats/min as reference)			14.798	0.005
66–72 beats/min	−0.015	0.135	0.012	0.913	0.985 (0.756–1.284)
72–78 beats/min	−0.057	0.123	0.212	0.646	0.945 (0.742–1.203)
78–84 beats/min	0.227	0.121	3.532	0.060	1.255 (0.990–1.590)
≥84 beats/min	0.309	0.122	6.365	0.012	1.361 (1.071–1.730)